FTC Approves Sale of MedCath’s Heart Hospital of New Mexico to Lovelace Health

The FTC has approved the sale of MedCath’s Heart Hospital of New Mexico in Albuquerque to Albuquerque-based Lovelace Health System, according to an FTC list of early terminations granted on May 27.

Advertisement

Early this month Lovelace signed a definitive agreement to purchase the assets and operations of 55-bed Heart Hospital of New Mexico from Charlotte, N.C.-based MedCath.

As part of the deal, Lovelace Health System, which is owned by Nashville, Tenn.-based Ardent Health Services, will pay $119 million for the hospital.

Related Articles on MedCath:
MedCath Seeks Stockholder Approval to Dissolve Company
New Mexico’s Lovelace Health System Buys Heart Hospital From MedCath
MedCath to Sell Arkansas Heart Hospital

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.